|
NL297170A
(enExample)
*
|
1963-04-04 |
1900-01-01 |
|
|
|
NL128365C
(enExample)
|
1963-11-05 |
|
|
|
|
US3449427A
(en)
*
|
1965-06-03 |
1969-06-10 |
Smithkline Corp |
Aminocyclopropane derivatives of 5h-dibenzo(a,d)cycloheptenes
|
|
US3697506A
(en)
|
1970-08-07 |
1972-10-10 |
Pfizer |
Crystalline alkali metal salts of {60 -carboxybenzylpenicillin and process therefor
|
|
US3686335A
(en)
*
|
1970-12-21 |
1972-08-22 |
Smith Kline French Lab |
5-vinyl-5h-di benzo(a,d)cycloheptenes
|
|
US4432987A
(en)
|
1982-04-23 |
1984-02-21 |
Pfizer Inc. |
Crystalline benzenesulfonate salts of sultamicillin
|
|
US4547505A
(en)
*
|
1983-03-25 |
1985-10-15 |
Degussa Aktiengesellschaft |
N-Phenyl-N-'-cycloalkylalkanoylpiperazine useful as analgetics and process for its production
|
|
CS244821B2
(en)
|
1983-06-16 |
1986-08-14 |
Boehringer Ingelheim Ltd |
Production method of new substituted phenylalkyl(piperazinyl or homopiperazinyle)-prpylureas or thioureas
|
|
DE3418167A1
(de)
|
1984-05-16 |
1985-11-21 |
Bayer Ag, 5090 Leverkusen |
Verwendung von amiden zur verbesserung der kulturpflanzen-vertraeglichkeit von herbizid wirksamen heteroaryloxyacetamiden
|
|
DE3600288A1
(de)
|
1986-01-08 |
1987-07-16 |
Bayer Ag |
Verwendung von amiden zur verbesserung der kulturpflanzen-vertraeglichkeit von herbizid wirksamen sulfonylharnstoff-derivaten
|
|
DE3618004A1
(de)
|
1986-05-28 |
1987-12-03 |
Bayer Ag |
Verwendung von amiden zur verbesserung der kulturpflanzen-vertraeglichkeit von herbizid wirksamen sulfonyliso(thio)-harnstoff-derivaten
|
|
CA2071897A1
(en)
|
1989-12-28 |
1991-06-29 |
Richard A. Glennon |
Sigma receptor ligands and the use thereof
|
|
CA2033390A1
(en)
*
|
1989-12-29 |
1991-06-30 |
Susumu Nakagawa |
2-(2-cyclopropylpyrrolidin-4-ylthio) carbapenem derivatives
|
|
EP0603240B1
(en)
|
1991-08-22 |
1998-12-02 |
Monsanto Company |
Safening herbicidal pyrazolylsulfonylureas
|
|
DE4131139A1
(de)
|
1991-09-19 |
1993-03-25 |
Bayer Ag |
Verfahren zur herstellung von 1-fluor-cyclopropan-1-carbonsaeure
|
|
ATE202109T1
(de)
|
1993-03-12 |
2001-06-15 |
Upjohn Co |
Kristallines ceftiofur (freie säure)
|
|
EP0793653A1
(en)
|
1994-11-23 |
1997-09-10 |
Neurogen Corporation |
Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands
|
|
US5604253A
(en)
|
1995-05-22 |
1997-02-18 |
Merck Frosst Canada, Inc. |
N-benzylindol-3-yl propanoic acid derivatives as cyclooxygenase inhibitors
|
|
US5859246A
(en)
|
1997-01-30 |
1999-01-12 |
Neurogen Corporation |
1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands
|
|
EP0968200A1
(en)
|
1997-02-24 |
2000-01-05 |
ZymoGenetics, Inc. |
Calcitonin mimetics
|
|
US6160134A
(en)
|
1997-12-24 |
2000-12-12 |
Bristol-Myers Squibb Co. |
Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines
|
|
YU47600A
(sh)
|
1998-01-27 |
2002-09-19 |
Aventis Pharmaceuticals Products Inc. |
SUPSTITUISANI OKSOAZAHETEROCIKLIL INHIBITORI FAKTORA Xa
|
|
US6268367B1
(en)
|
1998-02-23 |
2001-07-31 |
Zymogenetics, Inc. |
Piperazine derivatives for treating bone deficit conditions
|
|
WO2000000492A1
(en)
|
1998-06-26 |
2000-01-06 |
Chugai Seiyaku Kabushiki Kaisha |
FINE POWDER OF L-α-AMINOADIPIC ACID DERIVATIVE, ORAL SOLID PREPARATIONS CONTAINING THE SAME, AND METHOD FOR TREATMENT OF BULK POWDERS
|
|
AU771199B2
(en)
|
1999-01-08 |
2004-03-18 |
Neurogen Corporation |
1-phenyl-4-(1-(2-aryl)cyclopropyl) methylpiperazines: dopamine receptor ligands
|
|
US6284761B1
(en)
*
|
1999-01-08 |
2001-09-04 |
Neurogen Corporation |
1-phenyl-4-(1-[2-aryl]cyclopropyl)methylpiperazines: dopamine receptor ligands
|
|
AU5426500A
(en)
|
1999-06-16 |
2001-01-02 |
Takeda Chemical Industries Ltd. |
Benzazepine derivatives, process for the preparation of the same and uses thereof
|
|
WO2001022963A1
(en)
|
1999-09-27 |
2001-04-05 |
Merck & Co., Inc. |
Method of preventing osteoporosis
|
|
IL150524A0
(en)
|
2000-01-07 |
2003-02-12 |
Transform Pharmaceuticals Inc |
High-throughput formation, identification, and analysis of diverse solid-forms
|
|
US6521619B2
(en)
*
|
2000-06-29 |
2003-02-18 |
Icos Corporation |
Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agents
|
|
WO2002002522A1
(en)
|
2000-06-29 |
2002-01-10 |
Abbott Laboratories |
Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
|
|
IL153884A0
(en)
|
2000-07-20 |
2003-07-31 |
Neurogen Corp |
Capsaicin receptor ligands
|
|
JPWO2002051781A1
(ja)
|
2000-12-25 |
2004-04-22 |
味の素株式会社 |
光学活性ハロヒドリン化合物の製造方法
|
|
MXPA03007621A
(es)
|
2001-02-23 |
2003-12-04 |
Merck & Co Inc |
Antagonistas nr2b de n-metil-d-aspartato no arilheterociclicos n-sustituidos.
|
|
WO2003004480A2
(en)
|
2001-07-02 |
2003-01-16 |
Novo Nordisk A/S |
Substituted piperazine and diazepanes as histamine h3 receptor agonists
|
|
EP1422228A1
(en)
|
2001-08-08 |
2004-05-26 |
Takeda Chemical Industries, Ltd. |
BENZAZEPINE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE
|
|
WO2003026572A2
(en)
|
2001-09-26 |
2003-04-03 |
Merck & Co., Inc. |
Crystalline forms of ertapenem sodium
|
|
AU2002363236A1
(en)
|
2001-10-30 |
2003-05-12 |
Millennium Pharmaceuticals, Inc. |
Compounds, pharmaceutical compositions and methods of use therefor
|
|
US6861432B2
(en)
*
|
2001-11-23 |
2005-03-01 |
Schering Aktiengesellschaft |
Piperazine derivatives that destabilize androgen receptors
|
|
JP2005526800A
(ja)
|
2002-03-22 |
2005-09-08 |
エルジー・ライフ・サイエンシーズ・リミテッド |
（２Ｓ）−Ｎ−５−［アミノ（イミノ）メチル］−２−チエニルメチル−１−（２Ｒ）−２−［（カルボキシルメチル）アミノ］−３，３−ジフェニルプロパノイル−２−ピロリジンカルボキサミド・ｎＨ２Ｏの新しい結晶形
|
|
WO2003103666A2
(en)
|
2002-06-07 |
2003-12-18 |
Altana Pharma Ag |
Novel 4,5-dihydro-imidazo[4,5,1-ij]quinolin-6-ones
|
|
US20040077618A1
(en)
|
2002-10-22 |
2004-04-22 |
Bennani Youssef L. |
Cycloalkylamides and their therapeutic applications
|
|
US20040209858A1
(en)
*
|
2002-10-22 |
2004-10-21 |
Bennani Youssef L. |
Cycloalkylamides and their therapeutic applications
|
|
AU2003284402A1
(en)
|
2002-11-15 |
2004-06-15 |
Yamanouchi Pharmaceutical Co., Ltd. |
Antagonist to melanin-concentrating hormone receptor
|
|
ES2298627T3
(es)
|
2002-12-13 |
2008-05-16 |
Smithkline Beecham Corporation |
Compuestos de ciclopropilo como antagonistas de ccr5.
|
|
HRP20080541T3
(en)
|
2003-04-23 |
2008-12-31 |
Glaxo Group Limited |
Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases
|
|
EP1617840A4
(en)
|
2003-05-01 |
2008-08-20 |
Bristol Myers Squibb Co |
PYRAZOLE AMID COMPOUNDS AS KINASE INHIBITORS
|
|
TWI339206B
(en)
|
2003-09-04 |
2011-03-21 |
Vertex Pharma |
Compositions useful as inhibitors of protein kinases
|
|
ZA200605248B
(en)
|
2003-12-15 |
2007-10-31 |
Japan Tobacco Inc |
Cyclopropane compounds and pharmaceutical use thereof
|
|
BRPI0418939A
(pt)
|
2004-07-06 |
2008-04-08 |
Xenon Pharmaceuticals Inc |
derivados de nicotinamida e sua utilização como agentes terapêuticos
|
|
AR050865A1
(es)
|
2004-09-09 |
2006-11-29 |
Sanofi Aventis |
Derivados de 2- morfolino-4-pirimidona
|
|
BRPI0515851A
(pt)
|
2004-09-29 |
2008-08-12 |
Mitsubishi Pharma Corp |
composto de pirimidona
|
|
US20080045506A1
(en)
|
2004-10-15 |
2008-02-21 |
Glaxo Group Limited |
Pyrrolidine Derivatives as Histamine Receptors Ligands
|
|
BRPI0517423A
(pt)
|
2004-12-27 |
2008-10-07 |
Astrazeneca Ab |
composto, composição farmacêutica, método para o tratamento ou prevenção de distúrbios neurológicos e psiquiátricos associados com disfunção do glutamato em um animal, e, uso em um composto
|
|
CA2595882A1
(en)
|
2005-01-26 |
2006-08-03 |
Pharmacia & Upjohn Company Llc |
Thieno [2,3-d] pyrimidine compounds as inhibitors of adp-mediated platelets aggregation
|
|
JP2008530162A
(ja)
|
2005-02-15 |
2008-08-07 |
グラクソ グループ リミテッド |
グルタミン酸受容体を増強する化合物および医薬におけるそれらの使用
|
|
MX2007010076A
(es)
|
2005-02-17 |
2007-10-16 |
Astellas Pharma Inc |
Derivado de heterociclico-1-carboxilato que contiene nitrogeno no aromatico de piridilo.
|
|
WO2006100591A1
(en)
|
2005-03-25 |
2006-09-28 |
Pharmacia & Upjohn Company Llc |
4-piperazinnylthieno [2,3-d] pyrimidine compounds as platelet aggregation inhibitors
|
|
CA2602227A1
(en)
|
2005-03-28 |
2006-10-05 |
Michael Dalton Ennis |
4-piperazinylthieno [2,3-d] pyrimidine compounds as platelet aggregation inhibitors
|
|
EP1896483A2
(en)
|
2005-03-28 |
2008-03-12 |
Pharmacia & Upjohn Company LLC |
4-piperazinylthieno [2, 3-d] pyrimidine compounds as platelet aggregation inhibitors
|
|
CA2602538A1
(en)
|
2005-03-28 |
2006-10-05 |
Pharmacia & Upjohn Company Llc |
4-piperazinothieno [2, 3-d] pyrimidine compounds as platelet aggregation inhibitors
|
|
CN101263125A
(zh)
|
2005-07-15 |
2008-09-10 |
先灵公司 |
用于癌症治疗的喹唑啉衍生物
|
|
TW200740779A
(en)
|
2005-07-22 |
2007-11-01 |
Mitsubishi Pharma Corp |
Intermediate compound for synthesizing pharmaceutical agent and production method thereof
|
|
WO2007016496A2
(en)
|
2005-08-02 |
2007-02-08 |
Neurogen Corporation |
Dipiperazinyl ketones and related analogues
|
|
KR101336106B1
(ko)
*
|
2005-09-16 |
2013-12-05 |
얀센 파마슈티카 엔.브이. |
히스타민 ｈ3 수용체의 조절제로서 사이클로프로필 아민
|
|
US8158673B2
(en)
|
2005-10-27 |
2012-04-17 |
Pfizer Inc. |
Histamine-3 receptor antagonists
|
|
DK1951699T3
(da)
|
2005-10-31 |
2013-01-14 |
Janssen Pharmaceutica Nv |
Fremgangsmåder til fremstilling af cyclopropylamidderivater
|
|
WO2007075895A2
(en)
|
2005-12-21 |
2007-07-05 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic derivatives as modulators of ion channels
|
|
WO2007076140A2
(en)
|
2005-12-23 |
2007-07-05 |
University Of Cincinnati |
Treatment methods employing histamine h3 receptor antagonists, including betahistine
|
|
BRPI0707916A2
(pt)
*
|
2006-01-13 |
2011-05-17 |
Hoffmann La Roche |
compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem e uso destes compostos
|
|
CN101384581B
(zh)
|
2006-02-17 |
2013-09-18 |
弗·哈夫曼-拉罗切有限公司 |
作为5ht2/d3调节剂的苯甲酰基-哌啶衍生物
|
|
US20100006010A1
(en)
|
2006-03-01 |
2010-01-14 |
Ihor Hinczak |
Matrix for masonry elements and method of manufacture thereof
|
|
JP2009132621A
(ja)
|
2006-03-13 |
2009-06-18 |
Ajinomoto Co Inc |
シクロプロピルアミド化合物の製造方法
|
|
AU2007231594A1
(en)
|
2006-03-23 |
2007-10-04 |
Amgen Inc. |
1-phenylsulfonyl-diaza heterocyclic amide compounds and their uses as modulators of hydroxsteroid dehydrogenases
|
|
WO2007138928A1
(ja)
|
2006-05-26 |
2007-12-06 |
Kaneka Corporation |
光学活性３－アミノ－２－ヒドロキシプロピオン酸シクロプロピルアミド誘導体およびその塩の製造方法
|
|
CA2655604C
(en)
*
|
2006-06-23 |
2016-08-09 |
Abbott Laboratories |
Cyclopropyl amine derivatives
|
|
US9108948B2
(en)
*
|
2006-06-23 |
2015-08-18 |
Abbvie Inc. |
Cyclopropyl amine derivatives
|
|
AU2007271187A1
(en)
|
2006-07-03 |
2008-01-10 |
Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg |
Fused bicyclic compounds interacting with the histamine H4 receptor
|
|
US20090247499A1
(en)
|
2006-08-21 |
2009-10-01 |
Fletcher Joan M |
Sulfonylated piperazines as cannabinoid-1 receptor modulators
|
|
TW200828371A
(en)
|
2006-09-21 |
2008-07-01 |
Matsushita Electric Industrial Co Ltd |
Chip-type filter
|
|
DE102006056526A1
(de)
|
2006-11-30 |
2008-06-05 |
Archimica Gmbh |
Verfahren zur stereoselektiven Synthese von chiralen Epoxiden durch ADH-Reduktion von alpha-Abgangsgruppen-substituierten Ketonen und Cyclisierung
|
|
US7737149B2
(en)
|
2006-12-21 |
2010-06-15 |
Astrazeneca Ab |
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof
|
|
WO2008147864A2
(en)
*
|
2007-05-22 |
2008-12-04 |
Xenon Pharmaceuticals Inc. |
Methods of using piperazine compounds in treating sodium channel-mediated diseases or conditions
|
|
US8030495B2
(en)
|
2007-05-23 |
2011-10-04 |
Coleman Paul J |
Cyclopropyl pyrrolidine orexin receptor antagonists
|
|
JP2010529157A
(ja)
*
|
2007-06-11 |
2010-08-26 |
エフ．ホフマン−ラ ロシュ アーゲー |
シクロヘキシル誘導体
|
|
BRPI0815591B8
(pt)
*
|
2007-08-22 |
2021-05-25 |
Astrazeneca Ab |
composto, composição farmacêutica, e, uso de um composto.
|
|
KR101178674B1
(ko)
|
2007-10-04 |
2012-08-30 |
에프. 호프만-라 로슈 아게 |
사이클로프로필 아릴 아마이드 유도체 및 이의 용도
|
|
AR070107A1
(es)
|
2008-01-15 |
2010-03-17 |
Lilly Co Eli |
R-2-(4-ciclopropansulfonil-fenil)-n-pirazin-2-il-3-(tetrahidropiran-4-il)-propionamida en forma cristalina, composicion farmaceutica que la comprende y su uso para la manufactura de un medicamento util para la prevencion o tratamiento de hiperglicemia
|
|
DE102008049371A1
(de)
|
2008-03-06 |
2009-09-10 |
Mühlbauer Ag |
Einrichtung mit einem RFID-Transponder in einem elektrisch leitfähigen Gegenstand und Herstellungsverfahren hierfür
|
|
CA2721303C
(en)
|
2008-05-08 |
2016-06-28 |
Evotec Ag |
Azetidines and cyclobutanes as histamine h3 receptor antagonists
|
|
JP2012503595A
(ja)
|
2008-07-28 |
2012-02-09 |
シダンスク ユニバーシティ |
代謝病の治療用の化合物
|
|
CN101462980B
(zh)
|
2009-01-05 |
2013-01-09 |
扬州天辰精细化工有限公司 |
2，6—二氟苯甲酰胺的工业化生产方法
|
|
TW201039825A
(en)
|
2009-02-20 |
2010-11-16 |
Astrazeneca Ab |
Cyclopropyl amide derivatives 983
|
|
AU2011218491C1
(en)
*
|
2010-02-18 |
2015-05-14 |
Astrazeneca Ab |
Processes for making cyclopropyl amide derivatives and intermediates associated therewith
|
|
MX2012009537A
(es)
*
|
2010-02-18 |
2012-08-31 |
Astrazeneca Ab |
Formas solidas que comprenden un derivado de ciclopropilamida.
|